Related Experiment Videos
Impairment of memory and plasma flunitrazepam levels
S R Bareggi1, L Ferini-Strambi, R Pirola
1Department of Pharmacology, State University, School of Medicine, Milano, Italy.
Psychopharmacology
|December 22, 1998
Summary
Flunitrazepam impairs memory at lower doses than it affects attention. This study shows that even 2 mg of flunitrazepam significantly impacted explicit memory recall, while higher concentrations were needed to affect attention.
Area of Science:
- Pharmacology
- Cognitive Neuroscience
Background:
- Flunitrazepam is a benzodiazepine with known sedative and amnestic effects.
- Understanding dose-dependent cognitive effects is crucial for clinical safety.
Purpose of the Study:
- To investigate the dose-response relationship between oral flunitrazepam and cognitive functions.
- To compare the effects on psychomotor sedation, attention, working memory, and explicit memory.
Main Methods:
- Double-blind, placebo-controlled study with 36 healthy males.
- Oral administration of placebo or flunitrazepam (1, 2, or 4 mg).
- Cognitive testing at 3.5 and 10 hours post-dose, with plasma drug level analysis.
Main Results:
- 4 mg flunitrazepam significantly impaired psychomotor sedation, attention, working memory, and immediate recall.
- 2 mg and 4 mg doses significantly reduced explicit memory recall.
- Lower plasma concentrations of flunitrazepam were required to impair memory compared to attention.
Conclusions:
- Flunitrazepam exhibits a dose-dependent effect on cognitive functions.
- Memory impairment occurs at lower plasma concentrations than attention deficits.
- These findings highlight differential sensitivity of cognitive domains to flunitrazepam.